Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lavan Keith — Petros Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Lavan Keith

Lavan Keith

Chief Financial Officer at Petros Pharmaceuticals, Inc. · on record since Dec 3, 2020

Insider trading activity of Lavan Keith

Transactions on record: 1; since Dec 3, 2020

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 3, 2020

Figures computed from official regulatory filings — methodology.

Companies where Lavan Keith has traded

Petros Pharmaceuticals, Inc.1 tx · Dec 3, 2020

Track record of Lavan Keith

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lavan Keith

Co-insiders of Lavan Keith

Arnold MitchellPetros Pharmaceuticals, Inc.
Bernstein BrucePetros Pharmaceuticals, Inc.
Boctor FadyPetros Pharmaceuticals, Inc.
Bradley GregPetros Pharmaceuticals, Inc.
Gesek AndrewPetros Pharmaceuticals, Inc.
JCP III SM AIV, L.P.Petros Pharmaceuticals, Inc.
Juggernaut Partners III GP, L.P.Petros Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Juggernaut Partners III GP, Ltd.Petros Pharmaceuticals, Inc.

METP Holdings LLCPetros Pharmaceuticals, Inc.

Metuchen Therapeutics, LLCPetros Pharmaceuticals, Inc.

SHULMAN JOHN DPetros Pharmaceuticals, Inc.

Silverman JoshuaPetros Pharmaceuticals, Inc.

WALKER WAYNE REMELLPetros Pharmaceuticals, Inc.

WEINSTEIN ROBERTPetros Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Petros Pharmaceuticals, Inc.	Dec 3, 2020	Award	975	—	—	SEC